Type I interferon limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice

Antiviral Res. 2013 Sep;99(3):230-7. doi: 10.1016/j.antiviral.2013.05.007. Epub 2013 May 28.

Abstract

Antiviral immune responses play as a double edged sword in resolution of infection and pathogenesis of acute lung injury caused by infection with highly pathogenic influenza A viruses. Here we show that type I interferons (IFNs) are important in protection against acute influenza A virus infection not only via their antiviral activity but also via their anti-inflammatory activity. IFN α receptor (IFNAR) knock-out (KO) mice exhibited increased mortality and morbidity with higher viral load after infection with influenza virus A/FM/1/47 (H1N1, a mouse-adapted strain) compared with wild-type (WT) mice, though the viruses were finally eliminated in both groups. The levels of proinflammatory cytokines in the lungs were significantly higher, while the level of IL-10 in the lungs was significantly lower in IFNAR KO mice than in WT mice during the course of infection. Restoration of IL-10 during an ongoing virus infection significantly reduced the levels of proinflammatory cytokines and improved mortality of IFNAR KO mice. These results suggest that type I IFNs are responsible not only for direct resolution of viral load but also for suppression of immunopathology caused by influenza A virus through IL-10 production.

Keywords: Acute lung injury; Influenza; Interleukin-10; Type I interferon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / drug therapy*
  • Acute Lung Injury / immunology*
  • Acute Lung Injury / mortality
  • Acute Lung Injury / virology
  • Animals
  • Antiviral Agents / administration & dosage*
  • Down-Regulation / drug effects
  • Female
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • Influenza A Virus, H1N1 Subtype / genetics
  • Influenza A Virus, H1N1 Subtype / physiology
  • Influenza, Human / drug therapy*
  • Influenza, Human / immunology*
  • Influenza, Human / mortality
  • Influenza, Human / virology
  • Interferon Type I / administration & dosage*
  • Interleukin-10 / genetics
  • Interleukin-10 / immunology
  • Lung / drug effects
  • Lung / immunology
  • Lung / virology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptor, Interferon alpha-beta / deficiency
  • Receptor, Interferon alpha-beta / genetics

Substances

  • Antiviral Agents
  • Interferon Type I
  • Interleukin-10
  • Receptor, Interferon alpha-beta